{"id":"https://genegraph.clinicalgenome.org/r/fd8ba910-9ccd-49a3-b154-6dc11e4b4a25v1.0","type":"EvidenceStrengthAssertion","dc:description":"The *EIF2S3* gene encodes the γ subunit of eukaryotic translation initiation factor-2 (eIF2), a heterotrimeric GTP-binding protein involved in the recruitment of methionyl-tRNA(i) to the 40S ribosomal subunit. The acronym MEHMO (mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly, obesity) was coined by Steinmuller et al (PMID: 9781023) who described a large three-generation family with five affected boys and mapped the disease locus to the short arm of chromosome X. Using chromosome X-exome sequencing, Skopkova et al. (2017) identified a frameshift mutation I465Sfs in *EIF2S3* in an affected male in the family reported by Steinmüller et al (1998). Functional assays using a yeast/human (Sc/Hs) chimeric form of eIF2γ in yeast demonstrated the variant impairs eIF2γ function. The same variant was also detected in other 3 unrelated families with typical MEHMO syndrome features in affected males. Sequencing data suggested a founder effect for this variant (PMID: 28055140, 27333055, 29303605). Five missense mutations, which exhibited reduced growth rate and/or impaired translation function in yeast, were also reported in male patients exhibiting either typical features of MEHMO or milder phenotypes with a subset of MEHMO features, supporting clinically variable expressivity of MEHMO in patients with deleterious *EIF2S3* variants (PMID: 23063529, 27333055, 30878599, 32799315). The association is seen in 14 probands in 6 publications (PMID: 27333055, 28055140, 23063529, 29303605, 30878599, 32799315). The mechanism for disease is expected to be hemizygous loss of function. All reported female carriers are asymptomatic. Morpholino-based knockdown of the zebrafish *EIF2S3* ortholog recapitulates the human microcephaly and short stature phenotype (PMID: 27333055). An EIF2S3 knockdown human pancreatic β cell line showed impaired cell survival and increased caspase activities (PMID: 30878599). In summary, the *EIF2S3* /MEHMO syndrome gene-disease relationship is definitive. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This was approved the ClinGen Intellectual Disability Gene Curation Expert Panel on November 11, 2021 (SOP version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/fd8ba910-9ccd-49a3-b154-6dc11e4b4a25","GCISnapshot":"https://genegraph.clinicalgenome.org/r/bb96fe11-dd31-47b2-820d-9071035ec7b0","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/bb96fe11-dd31-47b2-820d-9071035ec7b0_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2021-11-11T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/bb96fe11-dd31-47b2-820d-9071035ec7b0_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2022-05-19T16:57:49.141Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb96fe11-dd31-47b2-820d-9071035ec7b0_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a588c9ad-b7e7-4fdb-b30b-85b25478a168","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a588c9ad-b7e7-4fdb-b30b-85b25478a168_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Studies in patient fibroblasts confirm increased the integrated stress response (ISR) activation due to the Ile465Serfs mutation and Yeast expressing yeast analogous mutation of Ile465Serfs exhibited growth defects.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a588c9ad-b7e7-4fdb-b30b-85b25478a168_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28055140","allele":{"id":"https://genegraph.clinicalgenome.org/r/52bdd315-354e-4584-b964-1df8962b0f32","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001415.4(EIF2S3):c.1394_1397del (p.Ile465fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10588829"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3c9d2aee-0882-4721-b2df-28d58f3a2cfb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c9d2aee-0882-4721-b2df-28d58f3a2cfb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional study in Yeast (I318M) showed that this variant I259M impaired protein synthesis and relaxed start codon selection stringency (performed in Gregory 2019, PMID: 30878599)\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3c9d2aee-0882-4721-b2df-28d58f3a2cfb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27333055","allele":{"id":"https://genegraph.clinicalgenome.org/r/70209357-42c9-4625-83c7-c73867f6899d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001415.4(EIF2S3):c.777T>G (p.Ile259Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10590051"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a553ace7-14c4-42a6-a26e-46ff4fe17e79","type":"EvidenceLine","dc:description":"Additional 0.5 is given because the variant is recurrent. The same variant has been reported in 3 different families including two Slovak, one Germany and one Southern Spain family. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a553ace7-14c4-42a6-a26e-46ff4fe17e79_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Studies in patient fibroblasts confirm increased the integrated stress response (ISR) activation due to the Ile465Serfs mutation and Yeast expressing yeast analogous mutation of Ile465Serfs exhibited growth defects. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a553ace7-14c4-42a6-a26e-46ff4fe17e79_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28055140","allele":{"id":"https://genegraph.clinicalgenome.org/r/52bdd315-354e-4584-b964-1df8962b0f32"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/f5fc51e9-7144-433b-b01e-18d2e00601bb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f5fc51e9-7144-433b-b01e-18d2e00601bb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Biochemical\nstudies of human cells overexpressing the eIF2γ mutant and of yeast eIF2γ with the analogous\nmutation revealed a defect in binding the eIF2β subunit to eIF2γ. Consistent with this loss of eIF2\nintegrity, the mutation in yeast eIF2γ impaired translation start codon selection and eIF2 function\nin vivo in a manner that was suppressed by overexpression of eIF2β.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/f5fc51e9-7144-433b-b01e-18d2e00601bb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23063529","allele":{"id":"https://genegraph.clinicalgenome.org/r/0617dae9-81ed-4e27-a790-dea9580f4587","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001415.4(EIF2S3):c.665T>C (p.Ile222Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10590050"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e7a66a14-5de7-455c-8745-2a7697676b17","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7a66a14-5de7-455c-8745-2a7697676b17_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Studies in patient fibroblasts confirm increased the integrated stress response (ISR) activation due to the Ile465Serfs mutation and Yeast expressing yeast analogous mutation of Ile465Serfs exhibited growth defects.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e7a66a14-5de7-455c-8745-2a7697676b17_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28055140","allele":{"id":"https://genegraph.clinicalgenome.org/r/52bdd315-354e-4584-b964-1df8962b0f32"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/14a25078-a712-48b6-bca9-c3f5a49208d8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14a25078-a712-48b6-bca9-c3f5a49208d8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Studies in yeast showed the yeast analogous mutant I218L reduced growth rates and lowered fidelity of translation. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/14a25078-a712-48b6-bca9-c3f5a49208d8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32799315","allele":{"id":"https://genegraph.clinicalgenome.org/r/b44408e0-4616-4dae-9f00-253195959187","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001415.4(EIF2S3):c.475A>T (p.Ile159Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA412594789"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d3b42611-b91a-4cd4-b2ab-08ad926d57b9","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d3b42611-b91a-4cd4-b2ab-08ad926d57b9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Studies in patient fibroblasts confirm increased the integrated stress response (ISR) activation due to the Ile465Serfs mutation and Yeast expressing yeast analogous mutation of Ile465Serfs exhibited growth defects.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d3b42611-b91a-4cd4-b2ab-08ad926d57b9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27333055","allele":{"id":"https://genegraph.clinicalgenome.org/r/52bdd315-354e-4584-b964-1df8962b0f32"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1c7068fc-0720-463f-bdc6-8377eba7c805","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1c7068fc-0720-463f-bdc6-8377eba7c805_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Yeast analogous mutant reduced the stringency of translation start site selection and enabled ribosomes to initiate translation at near-cognate non-AUG codons. in addition, whereas the yeast T203I (human T144I) mutation did not impact yeast cell growth, substitution of Ala (T203A) but not Lys (T203K) conferred a slow-growth phenotype.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1c7068fc-0720-463f-bdc6-8377eba7c805_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32799315","allele":{"id":"https://genegraph.clinicalgenome.org/r/003b1ac2-9aab-4323-8a19-2cecb3320226","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001415.4(EIF2S3):c.431C>T (p.Thr144Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA412594695"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bb96fe11-dd31-47b2-820d-9071035ec7b0_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3317807a-fb13-4188-9c42-57a7bbb7060f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28055140","rdfs:label":"Family 1","family":{"id":"https://genegraph.clinicalgenome.org/r/3317807a-fb13-4188-9c42-57a7bbb7060f","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/3073d397-1762-4fde-80b7-3d9553be2eef","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28055140","rdfs:label":"Index patient from family 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/52bdd315-354e-4584-b964-1df8962b0f32"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a553ace7-14c4-42a6-a26e-46ff4fe17e79_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/3073d397-1762-4fde-80b7-3d9553be2eef"}},{"id":"https://genegraph.clinicalgenome.org/r/a6082911-8d32-4d9f-aec0-6b1c52bfca6f_proband_segregation","type":"FamilyCosegregation","dc:description":"There are three affected members, but two of them are monozygotic twins. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30878599","rdfs:label":"Gregory 2019","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/a6082911-8d32-4d9f-aec0-6b1c52bfca6f","type":"Family","rdfs:label":"Gregory 2019","member":{"id":"https://genegraph.clinicalgenome.org/r/3f27eae6-b224-43c6-9883-55ce563e0be0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30878599","rdfs:label":"Patient III3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8a590a7a-1ccf-41ad-8c1e-2eaf0012a764","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001415.4(EIF2S3):c.1294C>T (p.Pro432Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA412598763"}},"phenotypeFreeText":"mild learning difficulties, hypopituitarism (GH and TSH deficiencies), and an unusual form of\nglucose dysregulation","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a3993860-f8ed-47b9-9e3b-371e26c52f03_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30878599","allele":{"id":"https://genegraph.clinicalgenome.org/r/8a590a7a-1ccf-41ad-8c1e-2eaf0012a764"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"mild learning difficulties, hypopituitarism (GH and TSH deficiencies), and an unusual form of\nglucose dysregulation","phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/3f27eae6-b224-43c6-9883-55ce563e0be0"}},{"id":"https://genegraph.clinicalgenome.org/r/8b9b14d7-9119-4f79-87ca-cd7be5a6f49d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32799315","rdfs:label":"Family 1","family":{"id":"https://genegraph.clinicalgenome.org/r/8b9b14d7-9119-4f79-87ca-cd7be5a6f49d","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/42b41e65-edad-49bd-a0aa-e2924cf8781f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32799315","rdfs:label":"III:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/003b1ac2-9aab-4323-8a19-2cecb3320226"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/1c7068fc-0720-463f-bdc6-8377eba7c805_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/42b41e65-edad-49bd-a0aa-e2924cf8781f"}},{"id":"https://genegraph.clinicalgenome.org/r/5556af1f-01b3-4dd5-962e-8752de0411e1_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27333055","rdfs:label":"Family 2","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/5556af1f-01b3-4dd5-962e-8752de0411e1","type":"Family","rdfs:label":"Family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/5b9d898b-3c2d-436a-ad1b-c867cb4d2ada","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27333055","rdfs:label":"IV.3","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/52bdd315-354e-4584-b964-1df8962b0f32"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d3b42611-b91a-4cd4-b2ab-08ad926d57b9_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":0,"proband":{"id":"https://genegraph.clinicalgenome.org/r/5b9d898b-3c2d-436a-ad1b-c867cb4d2ada"}},{"id":"https://genegraph.clinicalgenome.org/r/13d3e0e4-044a-4d98-b7d8-36f53a08ffd5_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32799315","rdfs:label":"Family 2","family":{"id":"https://genegraph.clinicalgenome.org/r/13d3e0e4-044a-4d98-b7d8-36f53a08ffd5","type":"Family","rdfs:label":"Family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/d0691f00-4acd-4cdc-ab53-d2af80ac183e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32799315","rdfs:label":"II:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/b44408e0-4616-4dae-9f00-253195959187"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/14a25078-a712-48b6-bca9-c3f5a49208d8_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/d0691f00-4acd-4cdc-ab53-d2af80ac183e"}},{"id":"https://genegraph.clinicalgenome.org/r/cd29e712-7ea0-48a5-a2bb-a919f3feee7e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28055140","rdfs:label":"Family 2","family":{"id":"https://genegraph.clinicalgenome.org/r/cd29e712-7ea0-48a5-a2bb-a919f3feee7e","type":"Family","rdfs:label":"Family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/95f87e2e-bb68-4fe0-83e0-a6f68c2773d2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28055140","rdfs:label":"Index patient in famly 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/52bdd315-354e-4584-b964-1df8962b0f32"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e7a66a14-5de7-455c-8745-2a7697676b17_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/95f87e2e-bb68-4fe0-83e0-a6f68c2773d2"}},{"id":"https://genegraph.clinicalgenome.org/r/471390ce-7373-4612-bd51-f4d76c60a3fb_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23063529","rdfs:label":"Borck 2012","family":{"id":"https://genegraph.clinicalgenome.org/r/471390ce-7373-4612-bd51-f4d76c60a3fb","type":"Family","rdfs:label":"Borck 2012","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/99f9eb13-5df4-47b2-a8d5-2239d06df5aa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23063529","rdfs:label":"Individual III:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/0617dae9-81ed-4e27-a790-dea9580f4587"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"phenotypeFreeText":"moderate-to-severe ID, microcephaly, short stature, and facial dysmorphic features","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f5fc51e9-7144-433b-b01e-18d2e00601bb_variant_evidence_item"}}},"phenotypeFreeText":"moderate-to-severe ID, microcephaly, short stature, and facial dysmorphic features","phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/99f9eb13-5df4-47b2-a8d5-2239d06df5aa"}},{"id":"https://genegraph.clinicalgenome.org/r/19c14f1e-f2b5-4db2-96de-f601cb23e734_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27333055","rdfs:label":"Family 1","family":{"id":"https://genegraph.clinicalgenome.org/r/19c14f1e-f2b5-4db2-96de-f601cb23e734","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/259d706a-9be5-4416-b41b-deba809f7dc2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27333055","rdfs:label":"proband III-2, proband III-3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":18,"allele":{"id":"https://genegraph.clinicalgenome.org/r/70209357-42c9-4625-83c7-c73867f6899d"},"phenotypeFreeText":"Severe microcephaly, growth retardation, epilepsy, and micropenis, with\nvarious degrees of severity","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3c9d2aee-0882-4721-b2df-28d58f3a2cfb_variant_evidence_item"}}},"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/259d706a-9be5-4416-b41b-deba809f7dc2"}},{"id":"https://genegraph.clinicalgenome.org/r/780edc48-73db-4171-8b17-8a6ce4b853f6_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28055140","rdfs:label":"Family 3","family":{"id":"https://genegraph.clinicalgenome.org/r/780edc48-73db-4171-8b17-8a6ce4b853f6","type":"Family","rdfs:label":"Family 3","member":{"id":"https://genegraph.clinicalgenome.org/r/ba8a9dae-3016-4dcb-98da-53f5d19a8c50","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28055140","rdfs:label":"Index patient in family 3","allele":{"id":"https://genegraph.clinicalgenome.org/r/52bdd315-354e-4584-b964-1df8962b0f32"},"detectionMethod":"X-exome","firstTestingMethod":"Exome sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a588c9ad-b7e7-4fdb-b30b-85b25478a168_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ba8a9dae-3016-4dcb-98da-53f5d19a8c50"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a3993860-f8ed-47b9-9e3b-371e26c52f03","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3993860-f8ed-47b9-9e3b-371e26c52f03_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In yeast, the variant caused impaired protein synthesis and relaxed start codon\nselection stringency. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a3993860-f8ed-47b9-9e3b-371e26c52f03_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11},{"id":"https://genegraph.clinicalgenome.org/r/bb96fe11-dd31-47b2-820d-9071035ec7b0_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb96fe11-dd31-47b2-820d-9071035ec7b0_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7100a5af-1818-44e7-af10-3e7b0011ba5b","type":"EvidenceLine","dc:description":"Reduce default 2 to 1 because the phenotypes in Zebrafish could only recapitulate some of the human phenotypes","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dbb2c398-5ca3-4489-b92e-6b4f171240a7","type":"Finding","dc:description":"Morpholino-based knockdown of the zebrafish EIF2S3 ortholog recapitulates the human microcephaly and short stature phenotype.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27333055","rdfs:label":"Morpholino-based knockdown","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/bb96fe11-dd31-47b2-820d-9071035ec7b0_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa7898ee-390a-4ff3-8c72-7ac6fa160af1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0302838f-4884-46b8-9717-a6b3d6b60105","type":"FunctionalAlteration","dc:description":"The cells transduced with LV vector encoding EIF2S3- targeting shRNA failed to survive for as long as control cell populations. Furthermore, the EIF2S3 KD cell line had significantly higher basal and cytokine-stimulated caspase activities compared to control cells, suggesting increased apoptosis. \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30878599","rdfs:label":"Apoptosis assay"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Definitive","sequence":4391,"specifiedBy":"GeneValidityCriteria8","strengthScore":12.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/X43r3FfrL7s","type":"GeneValidityProposition","disease":"obo:MONDO_0010258","gene":"hgnc:3267","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_bb96fe11-dd31-47b2-820d-9071035ec7b0-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}